Restricted accessResearch articleFirst published online 2020-03
Short Communication: Comparison of Calculated Low-Density Lipoprotein Cholesterol (LDL-C) Values in HIV-Infected and HIV-Uninfected Men Using the Traditional Friedewald and the Novel Martin–Hopkins LDL-C Equations
The Martin–Hopkins equation used to calculate low-density lipoprotein cholesterol (LDL-C) is more accurate than the traditional Friedewald equation, especially at higher triglyceride levels, which are more common in people with HIV (PWH). Thus, using LDL-C values calculated by the Martin–Hopkins equation may improve clinical care of PWH.
Get full access to this article
View all access options for this article.
References
1.
ChastainDB, Stover KR, Riche DM: Evidence-based review of statin use in patients with HIV on antiretroviral therapy. J Clin Transl Endocrinol 2017;8, 6–14.
2.
TriantVA, LeeH, HadiganC, GrinspoonSK: Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab, 2007; 92:2506–2512.
3.
LaurenceJ, ElhadadS, AhamedJ: HIV-associated cardiovascular disease: Importance of platelet activation and cardiac fibrosis in the setting of specific antiretroviral therapies. Open Heart, 2018; 5:DOI: 10.1136/openhrt-2018-000823.
4.
LoJ, LuMT, IhenachorEJ, WeiJ, LoobySE, FitchKV, et al.: Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: A randomised, double-blind, placebo-controlled trial. Lancet HIV, 2015; 2:e52–e63.
5.
GrundySM, StoneNJ, BaileyAL, BeamC, BirtcherKK, BlumenthalRS, et al.: 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: A report of the American college of Cardiology/American heart association task force on clinical practice guidelines. Circulation, 2019; 139:e1082–e1143.
6.
JacobsonTA, ItoMK, MakiKC, OrringerCE, BaysHE, JonesPH, et al.: National lipid association recommendations for patient-centered management of dyslipidemia: Part 1—Executive summary. J Clin Lipidol, 2014; 8:473–488.
7.
JacobsonTA, MakiKC, OrringerCE, JonesPH, Kris-EthertonP, SikandG, et al.: National lipid association recommendations for patient-centered management of dyslipidemia: Part 2. J Clin Lipidol, 2015; 9(6Suppl.):S1.e1–S122.e1.
8.
BautersC, TricotO, LemesleG, MeuriceT, HennebertO, FarnierM, et al.: Reaching low-density lipoprotein cholesterol treatment targets in stable coronary artery disease: Determinants and prognostic impact. Arch Cardiovasc Dis, 2018; 111:634–643.
9.
ZhangX, LiuJ, WangM, QiY, SunJ, LiuJ, et al.: Twenty-year epidemiologic study on LDL-C levels in relation to the risks of atherosclerotic event, hemorrhagic stroke, and cancer death among young and middle-aged population in china. J Clin Lipidol, 2018; 12:1179.e4–1189.e4.
10.
MillerWG, MyersGL, SakurabayashiI, BachmannLM, CaudillSP, DziekonskiA, et al.: Seven direct methods for measuring HDL and LDL cholesterol compared with ultracentrifugation reference measurement procedures. Clin Chem, 2010; 56:977–986.
11.
FriedewaldWT, LevyRI, FredricksonDS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18:499–502.
12.
MartinSS, BlahaMJ, ElshazlyMB, TothPP, KwiterovichPO, BlumenthalRS, et al.: Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. JAMA, 2013; 310:2061–2068.
13.
MartinSS, GiuglianoRP, MurphySA, WassermanSM, SteinEA, CeskaR, et al.: Comparison of low-density lipoprotein cholesterol assessment by Martin/Hopkins estimation, Friedewald estimation, and preparative ultracentrifugation: Insights from the FOURIER trial. JAMA Cardiol, 2018; 3:749–753.
14.
MehtaR, Reyes-RodriguezE, Yaxmehen Bello-ChavollaO, Guerrero-DiazAC, Vargas-VazquezA, Cruz-BautistaI, et al.: Performance of LDL-C calculated with martin's formula compared to the friedewald equation in familial combined hyperlipidemia. Atherosclerosis, 2018; 277:204–210.
15.
MikhailNE: LIPID abnormalities in patients infected with human immunodeficiency virus. Endocr Pract, 2008; 14:492–500.
